Medicare Enrolled
Dr. Qais Wahidi, M.D
Internal Medicine · Folsom, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wahidi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wahidi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wahidi
Dr. Qais Wahidi is an internal medicine specialist in Folsom, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Wahidi performed 8,817 Medicare services across 4,188 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wahidi received a total of $4,948 from 50 pharmaceutical and/or device companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wahidi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 3% volume in CA
$4,948 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,817
Medicare services
Top 3% in CA for internal medicine
4,188
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~519 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,444 | $91 | $410 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,035 | $46 | $90 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
510 | $38 | $150 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
493 | $35 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
490 | $67 | $332 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
296 | $85 | $175 |
| Annual alcohol misuse screening, 5 to 15 minutes | 296 | $20 | $40 |
| Annual depression screening | 275 | $20 | $45 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
271 | $138 | $300 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
215 | $33 | $80 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
212 | $76 | $135 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
182 | $9 | $30 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
142 | $44 | $80 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
142 | $128 | $250 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
120 | $1 | $5 |
| Adm sarscv2 bvl 50mcg/.5ml a | 118 | $44 | $90 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
117 | $2 | $9 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
112 | $6 | $15 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
96 | $11 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
87 | $141 | $493 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
70 | $54 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
59 | $10 | $80 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
58 | $238 | $450 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
55 | $91 | $245 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
51 | $27 | $40 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
38 | $174 | $400 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
30 | $20 | $144 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
22 | $11 | $70 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
21 | $38 | $110 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
19 | $176 | $326 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
18 | $14 | $40 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
16 | $103 | $250 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
16 | $5 | $21 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
15 | $50 | $150 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
14 | $6 | $18 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
14 | $50 | $150 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
14 | $283 | $500 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
14 | $33 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,948
Total received (2018-2024)
Avg $707/year across 7 years
Top 16% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,948 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$706
2023
$1,099
2022
$947
2021
$709
2020
$163
2019
$614
2018
$710
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$178
Lilly USA, LLC
$133
PFIZER INC.
$93
AstraZeneca Pharmaceuticals LP
$61
ABBVIE INC.
$43
Novo Nordisk Inc
$35
Exact Sciences Corporation
$24
Philips North America LLC
$24
Amgen Inc.
$24
Astellas Pharma US Inc
$21
Seqirus USA Inc
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Bausch Health US, LLC
$17
Dexcom, Inc.
$17
Top 3 companies account for 57.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$787
Novo Nordisk Inc
$626
AbbVie Inc.
$396
PFIZER INC.
$314
ABBVIE INC.
$245
Lilly USA, LLC
$222
AstraZeneca Pharmaceuticals LP
$156
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
Horizon Pharma plc
$143
Bausch Health US, LLC
$137
Amgen Inc.
$133
Synergy Pharmaceuticals Inc
$125
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$119
Janssen Pharmaceuticals, Inc
$90
Baxter Healthcare
$79
Abbott Laboratories
$79
Kowa Pharmaceuticals America, Inc.
$77
Exact Sciences Corporation
$76
SANOFI-AVENTIS U.S. LLC
$73
E.R. Squibb & Sons, L.L.C.
$72
Alfasigma USA, Inc.
$63
Allergan Inc.
$62
Biohaven Pharmaceuticals, Inc.
$60
Merck Sharp & Dohme Corporation
$60
AbbVie, Inc.
$56
IDORSIA PHARMACEUTICALS US INC
$36
Seqirus USA Inc
$36
Horizon Therapeutics plc
$32
Novartis Pharmaceuticals Corporation
$31
MEDICOMP INC
$29
DEXCOM, INC.
$27
Philips North America LLC
$24
VBI Vaccines (Delaware) Inc.
$23
SI-BONE, Inc.
$22
Daiichi Sankyo Inc.
$22
Merck Sharp & Dohme LLC
$21
Astellas Pharma US Inc
$21
Bioventus LLC
$20
Scilex Pharmaceuticals Inc.
$20
SANOFI PASTEUR INC.
$20
Amarin Pharma Inc.
$18
Sanofi Pasteur Inc.
$17
Dexcom, Inc.
$17
Resmed Corp
$17
MannKind Corporation
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
Actelion Pharmaceuticals US, Inc.
$16
Philips Electronics North America Corporation
$15
Acerus Pharmaceuticals Corporation
$15
Purdue Pharma L.P.
$12
Top 3 companies account for 36.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (CK7) Extended Holter · ABRYSVO · AFREZZA · AIRSUPRA · APLENZIN · AREXVY · Aimovig · AirSense · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · CHANTIX · CREON · Cardiac Monitor · Cologuard Collection Kit · Creon · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · Durolane · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · Fluad · Flucelvax · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL 9 · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · JARDIANCE · LEQVIO · LINZESS · LIVALO · Livalo · MOUNJARO · NUCALA · NURTEC ODT · Natesto · OFEV · OPSUMIT · Ozempic · PNEUMOVAX 23 · PRALUENT · PREMARIN · PREVNAR - 13 · PREVNAR 20 · PreHevbrio · QULIPTA · QUVIVIQ · RAYOS · RYBELSUS · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPRAVATO · SYMPROIC · Saxenda · Seglentis · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trulance · UBRELVY · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Veozah · Victoza · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZTLido · Zelnorm · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,172
Per 100K population
74.0
County median income
$88,724
Nearest hospital
MERCY HOSPITAL OF FOLSOM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wahidi is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wahidi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Wahidi performed 1,620 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wahidi receive payments from pharmaceutical companies?
Yes. Dr. Wahidi received a total of $4,948 from 50 companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wahidi's costs compare to other internal medicine physicians in Folsom?
Dr. Wahidi's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wahidi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Folsom
Browse internal medicine physicians in Folsom ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology